BUILD MODULE WITH DEFORMABLE WALL von Dummer, Timothy A

Volltext bestellen

BUILD MODULE WITH DEFORMABLE WALL von DUMMER, Timothy A

Volltext bestellen

Movement and the Rubber Hand Illusion von Dummer, Timothy, Picot-Annand, Alexandra, Neal, Tristan, Moore, Chris

Volltext

Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial von Prince, H Miles, Prof, Kim, Youn H, Prof, Horwitz, Steven M, MD, Dummer, Reinhard, Prof, Scarisbrick, Julia, MD, Quaglino, Pietro, Prof, Zinzani, Pier Luigi, Prof, Wolter, Pascal, MD, Sanches, Jose A, PhD, Ortiz-Romero, Pablo L, Prof, Akilov, Oleg E, MD, Geskin, Larisa, MD, Trotman, Judith, MD, Taylor, Kerry, MBBS, Dalle, Stephane, Prof, Weichenthal, Michael, Prof, Walewski, Jan, Prof, Fisher, David, MD, Dréno, Brigitte, Prof, Stadler, Rudolf, Prof, Feldman, Tatyana, MD, Kuzel, Timothy M, Prof, Wang, Yinghui, MS, Palanca-Wessels, Maria Corinna, MD, Zagadailov, Erin, PharmD, Trepicchio, William L, PhD, Zhang, Wenwen, PhD, Lin, Hui-Min, PhD, Liu, Yi, PhD, Huebner, Dirk, MD, Little, Meredith, MPH, Whittaker, Sean, Prof, Duvic, Madeleine, Prof

Volltext

Non-canonical Wnt Signaling through Ryk Regulates the Generation of Somatostatin- and Parvalbumin-Expressing Cortical Interneurons von McKenzie, Melissa G., Cobbs, Lucy V., Dummer, Patrick D., Petros, Timothy J., Halford, Michael M., Stacker, Steven A., Zou, Yimin, Fishell, Gord J., Au, Edmund

Volltext

Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial von Kim, Youn H, Bagot, Martine, Pinter-Brown, Lauren, Rook, Alain H, Porcu, Pierluigi, Horwitz, Steven M, Whittaker, Sean, Tokura, Yoshiki, Vermeer, Maarten, Zinzani, Pier Luigi, Sokol, Lubomir, Morris, Stephen, Kim, Ellen J, Ortiz-Romero, Pablo L, Eradat, Herbert, Scarisbrick, Julia, Tsianakas, Athanasios, Elmets, Craig, Dalle, Stephane, Fisher, David C, Halwani, Ahmad, Poligone, Brian, Greer, John, Fierro, Maria Teresa, Khot, Amit, Moskowitz, Alison J, Musiek, Amy, Shustov, Andrei, Pro, Barbara, Geskin, Larisa J, Dwyer, Karen, Moriya, Junji, Leoni, Mollie, Humphrey, Jeffrey S, Hudgens, Stacie, Grebennik, Dmitri O, Tobinai, Kensei, Duvic, Madeleine, Abhyankar, Sunil, Akilov, Oleg, Alpdogan, Onder, Beylot-Barry, Marie, Boh, Erin, Caballero, Dolores, Cowan, Richard, Dreno, Brigitte, Dummer, Reinhard, Fenske, Timothy, Foss, Francine, Fukuhara, Noriko, Giri, Pratyush, Habe, Koji, Hamada, Toshihisa, Hatake, Kiyohiko, Iida, Shinsuke, Ishikawa, Osamu, Iversen, Lars, Kiyohara, Eiji, Koga, Hiroshi, Korman, Neil, Kuss, Bryone Jean, Lamar, Zanetta, Lansigan, Frederick, Lechowicz, Mary Jo, Lerner, Adam, Magnolo, Nina, Mark, Lawrence, Miyagaki, Tomomitsu, Munoz, Javier, Nicolay, Jan Peter, Nishiwaki, Kaoru, Okamoto, Hiroyuki, Ohtsuka, Mikio, Pacheco, Theresa, Querfeld, Christiane, Rapini, Ronald Peter, Sano, Shigetoshi, Tanaka, Maiko, Tharp, Michael D., Uehara, Jiro, Wada, Hidefumi, Wells, Jillian, Wilcox, Ryan A., William, Basem, Yonekura, Kentaro

Volltext

Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controll... von Blank, Christian U, Mandalà, Mario, Long, Georgina V, Atkinson, Victoria G, Dalle, Stéphane, Haydon, Andrew M, Meshcheryakov, Andrey, Carlino, Matteo S, Sandhu, Shahneen, Larkin, James, Puig, Susana, Ascierto, Paolo A, Koornstra, Rutger, Hernandez-Aya, Leonel, Di Giacomo, Anna Maria, Grob, Jean-Jacques, Gutzmer, Ralf, Jamal, Rahima, Lorigan, Paul C, van Akkooi, Alexander C J, Krepler, Clemens, Ibrahim, Nageatte, Marreaud, Sandrine, Kicinski, Michal, Suciu, Stefan, Robert, Caroline, Menzies, Alex, Lesimple, Thierry, Maio, Michele, Brown, Michael, Hersey, Peter, Schachter, Jacob, Barrow, Catherine, Song, Xinni, Dutriaux, Caroline, Quaglino, Pietro, Meier, Friedegund, Stroyakovskiy, Daniil, Bastholt, Lars, Guillot, Bernard, Garbe, Claus, Ortiz Romero, Pablo Luis, Grange, Florent, Mohr, Peter, Algazi, Alain, Bechter, Oliver, Hernberg, Micaela, Arnault, Jean-Philippe, Loquai, Carmen, Meiss, Frank, Simon, Jan-Christoph, Bar-Sela, Gil, Chiarion Sileni, Vanna, Fitzharris, Bernard, McCrystal, Mike, Parente, Phillip, Baurain, Jean-Francois, Hauschild, Axel, Yamazaki, Naoya, Dummer, Reinhard, Walker, John, Geoffrois, Lionel, Leccia, Marie-Thérèse, Kretschmer, Lutz, Hendler, Daniel, Lotem, Michal, Mackiewicz, Andrzej, Sekulovic, Lidija, Dunwoodie, Elaine, Hoeller, Christoph, Machet, Laurent, Corrie, Philippa, Schmidt, Henrik, Descamps, Vincent, Kiecker, Felix, Ferrucci, Pier Francesco, Aarts, Maureen, Jameson, Michael, Ferreira, Paula, Kim, Kevin, Hofmann-Wellenhof, Reiner, Aubin, François, Utikal, Jochen, Ferraresi, Virginia, Inozume, Takashi, Kiyohara, Yoshio, Groenewegen, Gerard, Kapiteijn, Helena, Casasola, Richard, Crook, Timothy, Marshall, Ernest, Skytta, Tanja, Avril, Marie-Francoise, Jouary, Thomas, Hein, Rüdiger, Terheyden, Patrick, Straume, Oddbjorn, Martins, César, Mukhametshina, Guzel, Nathan, Paul

Volltext

Cemiplimab in locally advanced basal cell carcinoma after hedgehog inhibitor therapy: an open-label, multi-centre, single-arm, phase 2 trial von Stratigos, Alexander J, Sekulic, Aleksandar, Peris, Ketty, Bechter, Oliver, Prey, Sorilla, Kaatz, Martin, Lewis, Karl D, Basset-Seguin, Nicole, Chang, Anne Lynn S, Dalle, Stèphane, Orland, Almudena Fernandez, Licitra, Lisa, Robert, Caroline, Ulrich, Claas, Hauschild, Axel, Migden, Michael R, Dummer, Reinhard, Li, Siyu, Yoo, Suk-Young, Mohan, Kosalai, Coates, Ebony, Jankovic, Vladimir, Fiaschi, Nathalie, Okoye, Emmanuel, Bassukas, Ioannis D, Loquai, Carmen, De Giorgi, Vincenzo, Eroglu, Zeynep, Gutzmer, Ralf, Ulrich, Jens, Puig, Susana, Seebach, Frank, Thurston, Gavin, Weinreich, David M, Yancopoulos, George D, Lowy, Israel, Bowler, Timothy, Fury, Matthew G

Volltext

Targeting PHGDH Upregulation Reduces Glutathione Levels and Resensitizes Resistant NRAS-Mutant Melanoma to MAPK Kinase Inhibition von Nguyen, Mai Q., Teh, Jessica L.F., Purwin, Timothy J., Chervoneva, Inna, Davies, Michael A., Nathanson, Katherine L., Cheng, Phil F., Levesque, Mitchell P., Dummer, Reinhard, Aplin, Andrew E.

Volltext

Maximal surgical tumour load reduction in immune-checkpoint inhibitor naïve patients with melanoma brain metastases correlates with prolonged survival von Voglis, Stefanos, Schaller, Valentina, Müller, Timothy, Gönel, Meltem, Winklhofer, Sebastian, Mangana, Joana, Dummer, Reinhard, Serra, Carlo, Weller, Michael, Regli, Luca, Le Rhun, Emilie, Neidert, Marian C

Volltext

In Vivo E2F Reporting Reveals Efficacious Schedules of MEK1/2-CDK4/6 Targeting and mTOR-S6 Resistance Mechanisms von Teh, Jessica L F, Cheng, Phil F, Purwin, Timothy J, Nikbakht, Neda, Patel, Prem, Chervoneva, Inna, Ertel, Adam, Fortina, Paolo M, Kleiber, Ines, HooKim, Kim, Davies, Michael A, Kwong, Lawrence N, Levesque, Mitch P, Dummer, Reinhard, Aplin, Andrew E

Volltext

The retinoid X receptor agonist, 9-cis UAB30, inhibits cutaneous T-cell lymphoma proliferation through the SKP2-p27kip1 axis von Chou, Chu-Fang, Hsieh, Yu-Hua, Grubbs, Clinton J., Atigadda, Venkatram R., Mobley, James A., Dummer, Reinhard, Muccio, Donald D., Eto, Isao, Elmets, Craig A., Garvey, W. Timothy, Chang, Pi-Ling

Volltext

Encorafenib (enco) + binimetinib (bini) + pembrolizumab (pembro) for unresectable locally advanced or metastatic BRAF V600-mutant melanoma: Results from STARBOARD safety lead-in (S... von Schadendorf, Dirk, Dummer, Reinhard, Robert, Caroline, Ribas, Antoni, Sullivan, Ryan J., Panella, Timothy J., McKean, Meredith, Santos, Edgardo S., Clancy, Jill S., Thakur, Mahgull Nazar, Polli, Anna, Di Pietro, Alessandra, Ascierto, Paolo Antonio

Volltext

Maximal surgical tumour load reduction in immune-checkpoint inhibitor naïve patients with melanoma brain metastases correlates with prolonged survival von Voglis, Stefanos, Schaller, Valentina, Müller, Timothy, Gönel, Meltem, Winklhofer, Sebastian, Mangana, Joana, Dummer, Reinhard, Serra, Carlo, Weller, Michael, Regli, Luca, Le Rhun, Emilie, Neidert, Marian C.

Volltext

Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): health-related quality-of-life results from a double-blind, randomised, controlled... von Bottomley, Andrew, Blank, Christian U, Mandalà, Mario, Long, Georgina V, Atkinson, Victoria G, Khattak, Adnan, Carlino, Matteo S, Sandhu, Shahneen, Puig, Susana, Larkin, James, Lorigan, Paul C, Rutkowski, Piotr, Schadendorf, Dirk, Koornstra, Rutger, Hernandez-Aya, Leonel, Di Giacomo, Anna Maria, van den Eertwegh, Alfonsus J M, Grob, Jean-Jacques, Gutzmer, Ralf, Jamal, Rahima, Krepler, Clemens, Marreaud, Sandrine, Kicinski, Michal, Robert, Caroline, Lesimple, Thierry, Maio, Michele, Linette, Gerald, Mortier, Laurent, Svane, Inge Marie, Schachter, Jacob, Brown, Michael, Hersey, Peter, Barrow, Catherine, Kudchadkar, Ragini, Song, Xinni, Quaglino, Pietro, Queirolo, Paola, Stroyakovskiy, Daniil, Romero, Pablo Luis Ortiz, Bastholt, Lars, Garbe, Claus, Grange, Florent, Mohr, Peter, Bechter, Oliver, Loquai, Carmen, Meiss, Frank, Bar-Sela, Gil, Fitzharris, Bernard, Saiag, Philippe, Arnault, Jean-Philippe, Baurain, Jean-Francois, Combemale, Patrick, Dummer, Reinhard, Hauschild, Axel, Yamazaki, Naoya, Milhem, Mohammed, Kretschmer, Lutz, Dunwoodie, Elaine, Walker, John, Hendler, Daniel, Dzienis, Marcin, Hospers, Geke A.P., Hassel, Jessica, Passos, Maria-Jose, Levin, Max, Hoeller, Christoph, Machet, Laurent, Hallmeyer, Sigrun, Waterston, Ashita, Descamps, Vincent, Kiecker, Felix, Aarts, Maureen, Schmidt, Henrik, Raimundo, Ana, Lacour, Jean-Philippe, Berking, Carola, Ferrucci, Pier Francesco, Jameson, Michael, Kim, Kevin, Yokota, Kenji, Aubin, François, Kapiteijn, Helena, Boehncke, Wolf-Henning, Utikal, Jochen, Casasola, Richard, Marshall, Ernest, Richtig, Erika, Matkovic, Suzana, Crook, Timothy, Kiyohara, Yoshio, Avril, Marie-Francoise, Hein, Rüdiger, Nathan, Paul, Aoi, Jun, Skytta, Tanja, Jouary, Thomas, Takenouchi, Tatsuya, Straume, Oddbjorn, Martins, César, Mukhametshina, Guzel

Volltext

Phase 2 open-label, multicenter, single-arm study of cemiplimab in patients with locally advanced basal cell carcinoma after hedgehog inhibitor therapy: Extended follow-up von Stratigos, Alexander J., Sekulic, Aleksandar, Peris, Ketty, Bechter, Oliver, Prey, Sorilla, Lewis, Karl D., Basset-Seguin, Nicole, Chang, Anne Lynn S., Dalle, Stéphane, Fernández Orland, Almudena, Licitra, Lisa, Robert, Caroline, Ulrich, Claas, Hauschild, Axel, Migden, Michael R., Dummer, Reinhard, Yoo, Suk-Young, Okoye, Emmanuel, Bassukas, Ioannis, Loquai, Carmen, De Giorgi, Vincenzo, Eroglu, Zeynep, Gutzmer, Ralf, Ulrich, Jens, Puig, Susana, Inocencio, Timothy J., Chen, Chieh-I, LaFontaine, Patrick R., Seebach, Frank, Lowy, Israel, Fury, Matthew G.

Volltext

Alternative Strategies Used by People With Fibromyalgia to Decrease Pain and Increase Participation and Function von Kornblau, Barbara, Oliveira, Debora, Mbiza, Sarah, Forrest, Reva, Dummer, Mackenzie, Smith, Michael, Southerland, Timothy

Volltext

Abstract A22: Effects of CDK4/6/MAPK targeting combinations on melanoma and the tumor immune microenvironment von Teh, Jessica L.F., Cheng, Phil F., Erkes, Dan E., Purwin, Timothy J., Field, Conroy, Hollingworth, Connor, Aguirre-Ghiso, Julio, Levesque, Mitch P., Dummer, Reinhard, Aplin, Andrew E.

Volltext

STARBOARD: encorafenib + binimetinib + pembrolizumab for first-line metastatic/unresectable BRAF V600-mutant melanoma von Schadendorf, Dirk, Dummer, Reinhard, Robert, Caroline, Ribas, Antoni, Sullivan, Ryan J, Panella, Timothy, McKean, Meredith, Santos, Edgardo S, Brill, Kimberli, Polli, Anna, Pietro, Alessandra di, Ascierto, Paolo A

Volltext

Targeting PHGDH upregulation reduces glutathione levels and re-sensitizes resistant NRAS mutant melanoma to MEK inhibition von Nguyen, Mai Q., Teh, Jessica L.F., Purwin, Timothy J., Chervoneva, Inna, Davies, Michael A., Nathanson, Katherine L., Cheng, Phil F., Levesque, Mitchell P., Dummer, Reinhard, Aplin, Andrew E.

Volltext